Our 2nd newsletter showcases the highlights 2023 and key achievements of the programme “Quality Improvement of Integrated HIV, TB and Malaria Services in Antenatal and Postnatal Care”. The programme is funded by the Global Fund to Fight AIDS, Tuberculosis and Malaria with financing from Takeda Pharmaceutical Company Limited.
Our first newsletter showcases the highlights 2022 of the programme “Quality Improvement of Integrated HIV, TB and Malaria Services in Antenatal and Postnatal Care”. The programme is funded by the Global Fund to Fight AIDS, Tuberculosis and Malaria with financing from Takeda Pharmaceutical Company Limited.